The stock market briefly entered correction territory last week as concerns about the economic fallout from President Trump's trade policies grow.

NEW YORK, NY / ACCESS Newswire / March 23, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/merck-co-inc-lawsuit-submission-form?prid=138113&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / March 23, 2025 / If you suffered a loss on your Geron Corporation (NASDAQ:GERN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/geron-corporation-lawsuit-submission-form?prid=138112&wire=1 or contact Joseph E. Levi, Esq.

The Eldridge BBB-B CLO ETF offers liquid access to illiquid collateralised loan obligations, focusing on BBB-to-BBB rated tranches with variable-rate structures. The ETF maintains a significant 8% cash position, allowing strategic allocations and a capital buffer. Additionally, CLOZ is well-diversified across sectors and issuers, mitigating idiosyncratic risk. CLOZ seems more risky than its peer set. However, its returns can be compelling as a consequence.

NerdWallet, a founder-led company, is expanding into new verticals and geographies, growing its user base, and increasing revenues despite recent stock under-performance. The company shows strong revenue growth, has no long-term debt, and at a promising valuation, makes it an attractive buy during this market correction. Risks include competition from social media and AI, but NerdWallet's reliable content and marketplace experience offer a competitive edge.

NEW YORK, NY / ACCESS Newswire / March 23, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/maravai-lifesciences-holdings-inc-lawsuit-submission-form?prid=138106&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / March 23, 2025 / If you suffered a loss on your Fluence Energy, Inc. (NASDAQ:FLNC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fluence-energy-lawsuit-submission-form?prid=138111&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / March 23, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/gsk-lawsuit-submission-form?prid=138108&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / March 23, 2025 / If you suffered a loss on your Intellia Therapeutics, Inc. (NASDAQ:NTLA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/intellia-therapeutics-inc-lawsuit-submission-form?prid=138110&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / March 23, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=138105&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / March 23, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/neumora-therapeutics-inc-lawsuit-submission-form?prid=138107&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / March 23, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/icon-public-limited-company-lawsuit-submission-form?prid=138109&wire=1 or contact Joseph E. Levi, Esq.

Leveraged ETFs suffer from volatility drag, causing them to underperform their benchmarks, which can be exploited by shorting leveraged ETFs while buying the underlying asset. Backtesting since July 2023 shows a strategy of 67% BTC and 33% short BITX yielding a 34.03% annualized return with lower drawdowns. Adjusting the allocation to 75% BTC and 25% short BITX increases annualized returns to 45.73%, but with tail risk.

NEW YORK, NY / ACCESS Newswire / March 23, 2025 / If you suffered a loss on your Ready Capital Corporation (NYSE:RC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ready-capital-corporation-lawsuit-submission-form?prid=138099&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / March 23, 2025 / If you suffered a loss on your e.l.f. Beauty, Inc. (NYSE:ELF) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/e-l-f-beauty-lawsuit-submission-form?prid=138098&wire=1 or contact Joseph E.

I reiterate my strong buy rating for FactSet Research Systems (FDS) due to strong EPS growth, pipeline bookings, and AI-driven product traction. FDS reported 2Q25 revenue of $570.7 million, with a healthy EBIT margin of 37.3%, and increased FY25 revenue guidance to $2.305-$2.325 billion. FDS's AI strategy, particularly Pitch Creator, shows promising adoption, with >2,000 active trials and >50 pipeline opportunities, enhancing productivity for investment bankers.

NEW YORK, NY / ACCESS Newswire / March 23, 2025 / If you suffered a loss on your TFI International Inc. (NYSE:TFII) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/tfi-international-inc-lawsuit-submission-form?prid=138097&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / March 23, 2025 / If you suffered a loss on your Semtech Corporation (NASDAQ:SMTC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/semtech-corporation-lawsuit-submission-form?prid=138096&wire=1 or contact Joseph E. Levi, Esq.

RADNOR, Pa., March 23, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against e.l.f. Beauty, Inc. (“Elf”) (NYSE: ELF) on behalf of those who purchased or otherwise acquired Elf securities between November 1, 2023, and November 19, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is May 5, 2025.

George Noble is bearish on Tesla (TSLA), along with TAN, XRT, and XHB. He also says to “beware” of retail and housing stocks, expecting more pain to come.